Ci
Circassia
Oxford UKFounded 2006200 employees
Private CapbiotechAcquiredRespiratory
Platform: Niox Asthma
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niratenlimab | CIR-5743 | Phase 1 | 1 | USP1 | RettHS | ||
| CIR-2997 | CIR-2997 | Phase 2/3 | 2 | DLL3 | SCLC | ||
| Adagrainavolisib | CIR-8736 | Phase 2 | 2 | APOC3 | UCCholangiocarcinoma |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (7)